Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Ludwig

Showing results (21-30 of 267) with videos related to

Pageof 27
Sort By:
Leukemia|August 1, 1991
Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemiaH G Drexler, E Thiel, W D Ludwig
Leukemia & Lymphoma|July 29, 2016
Augmentation of the Susceptibility of Human Leukemia to Lymphokine-Activated Killer (LAK) Cells by Exposure of the Leukemic Target Cells to Cytotoxic Drugs in Vitro and in VivoJ V Teichmann, W D Ludwig, E Thiel
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Susceptibility of human leukemia cells to allogeneic and autologous lymphokine-activated killer cells and its augmentation by exposure of leukemia target cells to cytotoxic drugs in vitro and in vivoJ V Teichmann, W D Ludwig, E Thiel
International Journal of Hematology|June 1, 1992
GM-CSF-mediated proliferation induction improves the susceptibility of leukemia cells to lymphokine-activated killer cellsJ V Teichmann, W D Ludwig, E Thiel
Deutsche Medizinische Wochenschrift (1946)|May 11, 1990
[Therapy of malignant lymphoma]J V Teichmann, W D Ludwig, E Thiel
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1984
Monoclonal antibodies recognizing T-cells (Leu 1) and transferrin receptor (OKT 9) crossreact with malignant B-cells of distinct differentiation stagesW D Ludwig, P Kolecki, G Sieber, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 6, 2002
[Involvement of mitochondrial membrane potential in the homoharringtonine induced apoptosis of leukemic T-cells]Z Cai, M Lin, W D Ludwig, et al.
Leukemia Research|January 1, 1985
A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodiesF Herrmann, B Dörken, W D Ludwig, et al.
Blood|November 15, 1993
Selective targeting of human lymphokine-activated killer cells by CD3 monoclonal antibody against the interferon-inducible high-affinity Fc gamma RI receptor (CD64) on autologous acute myeloid leukemic blast cellsM Notter, W D Ludwig, S Bremer, et al.
Blut|September 1, 1983
Use of monoclonal antibodies as a diagnostic tool in human leukemia. I. Acute myeloid leukemia and acute phase of chronic myeloid leukemiaF Herrmann, B Komischke, E Odenwald, et al.
Pageof 27

Showing results (21-30 of 267) with videos related to

Sort By:
Pageof 27
Leukemia|August 1, 1991
Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemiaH G Drexler, E Thiel, W D Ludwig
Leukemia & Lymphoma|July 29, 2016
Augmentation of the Susceptibility of Human Leukemia to Lymphokine-Activated Killer (LAK) Cells by Exposure of the Leukemic Target Cells to Cytotoxic Drugs in Vitro and in VivoJ V Teichmann, W D Ludwig, E Thiel
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Susceptibility of human leukemia cells to allogeneic and autologous lymphokine-activated killer cells and its augmentation by exposure of leukemia target cells to cytotoxic drugs in vitro and in vivoJ V Teichmann, W D Ludwig, E Thiel
International Journal of Hematology|June 1, 1992
GM-CSF-mediated proliferation induction improves the susceptibility of leukemia cells to lymphokine-activated killer cellsJ V Teichmann, W D Ludwig, E Thiel
Deutsche Medizinische Wochenschrift (1946)|May 11, 1990
[Therapy of malignant lymphoma]J V Teichmann, W D Ludwig, E Thiel
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1984
Monoclonal antibodies recognizing T-cells (Leu 1) and transferrin receptor (OKT 9) crossreact with malignant B-cells of distinct differentiation stagesW D Ludwig, P Kolecki, G Sieber, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 6, 2002
[Involvement of mitochondrial membrane potential in the homoharringtonine induced apoptosis of leukemic T-cells]Z Cai, M Lin, W D Ludwig, et al.
Leukemia Research|January 1, 1985
A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodiesF Herrmann, B Dörken, W D Ludwig, et al.
Blood|November 15, 1993
Selective targeting of human lymphokine-activated killer cells by CD3 monoclonal antibody against the interferon-inducible high-affinity Fc gamma RI receptor (CD64) on autologous acute myeloid leukemic blast cellsM Notter, W D Ludwig, S Bremer, et al.
Blut|September 1, 1983
Use of monoclonal antibodies as a diagnostic tool in human leukemia. I. Acute myeloid leukemia and acute phase of chronic myeloid leukemiaF Herrmann, B Komischke, E Odenwald, et al.
Pageof 27